APA (7th ed.) Citation

Weishan, H., Donglin, Z., Guangmei, D., Wenya, L., Fasheng, W., & Jibing, C. (2024). Immunoradiotherapy for NSCLC: Mechanisms, clinical outcomes, and future directions. Clinical & translational oncology, 26(5), 1063-1076. https://doi.org/10.1007/s12094-023-03337-9

Chicago Style (17th ed.) Citation

Weishan, He, Zheng Donglin, Deng Guangmei, Liu Wenya, Wu Fasheng, and Chen Jibing. "Immunoradiotherapy for NSCLC: Mechanisms, Clinical Outcomes, and Future Directions." Clinical & Translational Oncology 26, no. 5 (2024): 1063-1076. https://doi.org/10.1007/s12094-023-03337-9.

MLA (9th ed.) Citation

Weishan, He, et al. "Immunoradiotherapy for NSCLC: Mechanisms, Clinical Outcomes, and Future Directions." Clinical & Translational Oncology, vol. 26, no. 5, 2024, pp. 1063-1076, https://doi.org/10.1007/s12094-023-03337-9.